Cantitate/Preț
Produs

The Carbonic Anhydrases: Current and Emerging Therapeutic Targets: Progress in Drug Research, cartea 75

Editat de W. Richard Chegwidden, Nicholas D. Carter
en Limba Engleză Paperback – 31 oct 2022
This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 71609 lei  6-8 săpt.
  Springer International Publishing – 31 oct 2022 71609 lei  6-8 săpt.
Hardback (1) 103850 lei  6-8 săpt.
  Springer International Publishing – 31 oct 2021 103850 lei  6-8 săpt.

Din seria Progress in Drug Research

Preț: 71609 lei

Preț vechi: 75377 lei
-5% Nou

Puncte Express: 1074

Preț estimativ în valută:
13704 14138$ 11598£

Carte tipărită la comandă

Livrare economică 05-19 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030795139
ISBN-10: 3030795136
Pagini: 288
Ilustrații: XII, 288 p. 38 illus., 22 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.43 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Seria Progress in Drug Research

Locul publicării:Cham, Switzerland

Cuprins

Dedication.- Preface.-The carbonic anhydrases in health and disease.- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets.- Targeting carbonic anhydrases in vascular and pulmonary disease.- Carbonic anhydrase inhibitors in ophthalmology:  glaucoma and macular oedema.- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders.- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes.- An overview of carbonic anhydrase-related neoplasms.- The carbonic anhydrase IX interactome and the regulation of cancer progression.- Carbonic anhydrase IX: current and emerging therapies.- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents.- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening.- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.

Textul de pe ultima copertă

This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.

Caracteristici

Focuses on carbonic anhydrases as potential therapeutic targets Covers clinical disciplines such as oncology, neurology, ophthalmology, and metabolic, vascular and pulmonary medicine Ensures its value to a broad readership through the comprehensive, inter-disciplinary nature of the text